MARKER THERAPEUTICS, INC. — Net Income by Fiscal Year
26 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/48be8d02-aec8-4ef2-91ba-7b2968226e02/serie/net-income
| Fiscal year | Net Income | Period | Evidence |
|---|---|---|---|
| FY 2025 | $-12.2M | 2025-01-01 – 2025-12-31 | evidence 0001104659-26-031274 |
| FY 2024 | $-10.7M | 2024-01-01 – 2024-12-31 | evidence 0001410578-25-000549 |
| FY 2023 | $-8.2M | 2023-01-01 – 2023-12-31 | evidence 0001410578-24-000297 |
| FY 2022 | $-29.9M | 2022-01-01 – 2022-12-31 | evidence 0001410578-23-000324 |
| FY 2021 | $-41.9M | 2021-01-01 – 2021-12-31 | evidence 0001410578-22-000418 |
| FY 2020 | $-28.7M | 2020-01-01 – 2020-12-31 | evidence 0001104659-21-033855 |
| FY 2019 | $-21.4M | 2019-01-01 – 2019-12-31 | evidence 0001104659-20-032463 |
| FY 2018 | $-148.0M | 2018-01-01 – 2018-12-31 | evidence 0001144204-19-014350 |
| FY 2017 | $-11.0M | 2017-01-01 – 2017-12-31 | evidence 0001144204-18-016734 |
| FY 2016 | $-2.5M | 2016-01-01 – 2016-12-31 | evidence 0001144204-17-014490 |
| FY 2015 | $-34.1M | 2015-01-01 – 2015-12-31 | evidence 0001193125-16-541539 |
| FY 2014 | $-30.9M | 2014-01-01 – 2014-12-31 | evidence 0001424884-15-000039 |
| FY 2013 | $-85.1M | 1999-07-27 – 2013-12-31 | evidence 0001424884-14-000063 |
| FY 2012 | $-50.3M | 1999-07-27 – 2013-03-31 | evidence 0001424884-13-000037 |
| FY 2011 | $-44.3M | 1999-07-27 – 2012-03-31 | evidence 0001424884-12-000038 |
| FY 2010 | $-3.5M | 2010-01-01 – 2010-12-31 | evidence 0001424884-12-000026 |
| FY 2009 | $-17.3M | 2009-01-01 – 2009-12-31 | evidence 0001424884-12-000026 |
| FY 2008 | $-2.2M | 2008-01-01 – 2008-12-31 | evidence 0001424884-12-000026 |
| FY 2007 | $-3.9M | 2007-01-01 – 2007-12-31 | evidence 0001424884-12-000026 |
| FY 2006 | $-1.3M | 2006-01-01 – 2006-12-31 | evidence 0001424884-12-000026 |
| FY 2005 | $-985.6k | 2005-01-01 – 2005-12-31 | evidence 0001424884-12-000026 |
| FY 2004 | $-2.7M | 2004-01-01 – 2004-12-31 | evidence 0001424884-12-000026 |
| FY 2003 | $-5.8M | 2003-01-01 – 2003-12-31 | evidence 0001424884-12-000026 |
| FY 2002 | $-2.3M | 2002-01-01 – 2002-12-31 | evidence 0001424884-12-000026 |
| FY 2001 | $-672.0k | 2001-01-01 – 2001-12-31 | evidence 0001424884-12-000026 |
| FY 2000 | $-935.3k | 2000-01-01 – 2000-12-31 | evidence 0001424884-12-000026 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
MARKER THERAPEUTICS, INC. — all facts · Revenue · Operating Income